Delivery Order SPE2DB22D1017-SPE2DB25FF9EC

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,012.53, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,437.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order. The contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLETS in quantities of 180 per order. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,586.27 and a period of performance through May 16, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG tablets for a total ceiling value of $1,086.48. It is a firm fixed-price delivery order contract with a performance period through January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a large...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,259.72 firm-fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,560.74, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication. The contract has a period of performance through January 21, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.96 firm fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG tablets. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $61,956.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 26, 2024. The award is not associated with a set-aside program and is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,649.82, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $37,051.05 and a completion date of January 2, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF9EC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,009.95 and a completion date of April 3, 2025. The contract was awarded on April 2, 2025 and does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/2/25, 10:41 PM